In scientific journals, authors and reviewers have praised companies in which they have substantial investments. These scientists, with their potential conflict of interest, call into question the integrity of scientific inquiry
there should be full public disclosure of scientific authors' commercial holdings.
Financial advisers should inform their clients about any incentives the advisers receive for promoting investments in particular companies.